Chemlite Innovation Berhad (KLSE:CLITE)
Malaysia · Delayed Price · Currency is MYR 0.1900
0.00 (0.00%)
At close: Sep 1, 2026
KLSE:CLITE Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 41.14 | 41.64 | 34.19 | 28.05 | 22.15 | 18.4 | |
Revenue Growth | 15.77% | 21.78% | 21.91% | 26.65% | 20.39% | - |
Cost of Revenue | 26.69 | 27.61 | 19.77 | 13.2 | 14.4 | 12.6 |
Gross Profit | 14.45 | 14.03 | 14.42 | 14.85 | 7.74 | 5.8 |
Selling, General & Admin | 9.42 | 8.88 | 6.26 | 5.03 | 3.32 | 3.49 |
Operating Expenses | 9.45 | 8.9 | 6.33 | 5.08 | 3.31 | 3.49 |
Operating Income | 5 | 5.13 | 8.1 | 9.77 | 4.44 | 2.31 |
Interest Expense | -0.6 | -0.78 | -1 | -0.53 | -0.32 | -0.34 |
Interest & Investment Income | 0.11 | 0.11 | 0.04 | 0.04 | 0.01 | 0 |
Currency Exchange Gain (Loss) | - | - | 0.05 | 0.3 | - | 0.02 |
Other Non Operating Income (Expenses) | 1.48 | 2.23 | 1.5 | 1.9 | 0.16 | 0.08 |
EBT Excluding Unusual Items | 5.99 | 6.7 | 8.68 | 11.48 | 4.29 | 2.06 |
Gain (Loss) on Sale of Assets | - | - | - | 1.01 | - | 0.24 |
Asset Writedown | - | - | - | -0.1 | - | - |
Other Unusual Items | 1 | - | - | -0.27 | -0.06 | - |
Pretax Income | 6.99 | 6.7 | 8.68 | 12.12 | 4.23 | 2.31 |
Income Tax Expense | 1.37 | 1.28 | -0.58 | 3.12 | 1.05 | 0.65 |
Net Income | 5.62 | 5.42 | 9.26 | 9 | 3.18 | 1.65 |
Net Income to Common | 5.62 | 5.42 | 9.26 | 9 | 3.18 | 1.65 |
Net Income Growth | -12.14% | -41.48% | 2.86% | 183.08% | 92.51% | - |
Shares Outstanding (Basic) | 601 | 573 | 258 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 601 | 573 | 258 | 2 | 2 | 2 |
Shares Change | 17.05% | 121.67% | 15558.22% | - | 3.55% | - |
EPS (Basic) | 0.01 | 0.01 | 0.04 | 5.45 | 1.93 | 1.04 |
EPS (Diluted) | 0.01 | 0.01 | 0.04 | 5.45 | 1.93 | 1.04 |
EPS Growth | -24.94% | -73.60% | -99.34% | 183.08% | 85.91% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.21 | -4.29 | 3.95 | 0.51 | 2.82 | -5.22 |
Free Cash Flow Per Share | -0.00 | -0.01 | 0.01 | 0.31 | 1.71 | -3.28 |
Dividend Per Share | - | - | - | - | 3.030 | 0.910 |
Dividend Growth | - | - | - | - | 232.97% | - |
Gross Margin | 35.12% | 33.70% | 42.18% | 52.94% | 34.96% | 31.52% |
Operating Margin | 12.15% | 12.33% | 23.68% | 34.84% | 20.03% | 12.56% |
Profit Margin | 13.66% | 13.01% | 27.08% | 32.09% | 14.36% | 8.98% |
Free Cash Flow Margin | -5.37% | -10.30% | 11.56% | 1.83% | 12.75% | -28.38% |
EBITDA | 7.73 | 7.53 | 10.05 | 10.46 | 4.66 | 2.57 |
EBITDA Margin | 18.78% | 18.08% | 29.40% | 37.28% | 21.05% | 13.97% |
D&A For EBITDA | 2.73 | 2.4 | 1.96 | 0.68 | 0.23 | 0.26 |
EBIT | 5 | 5.13 | 8.1 | 9.77 | 4.44 | 2.31 |
EBIT Margin | 12.15% | 12.33% | 23.68% | 34.84% | 20.03% | 12.56% |
Effective Tax Rate | 19.66% | 19.09% | - | 25.72% | 24.77% | 28.35% |